Copyright 2009 Medical News Today Latest Cervical Cancer / HPV Vaccine News From Medical News Today. http://www.medicalnewstoday.com/sections/cervical_cancer/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Sat, 04 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156243.php http://www.medicalnewstoday.com/articles/156243.php Even under favorable assumptions, including lifelong protection against 70% of all cervical cancers and no side effects, vaccination against the human papillomavirus (HPV) is not cost-effective in the Netherlands, according to a study published online July 1 in the Journal of the National Cancer Institute. Cervical Cancer / HPV Vaccine Fri, 26 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/155448.php http://www.medicalnewstoday.com/articles/155448.php New research, published in The Lancet Oncology, has found that combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase the detection of cervical cancer compared with LBC screening alone. The trial funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme aimed to determine whether testing for HPV in the cervix might increase the effectiveness of the cervical screening programme. Cervical Cancer / HPV Vaccine Thu, 25 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/155286.php http://www.medicalnewstoday.com/articles/155286.php There will be a new drive to ensure GPs spot cervical cancer symptoms earlier in young women and refer patients correctly, Health Minister Ann Keen announced today. Cervical Cancer / HPV Vaccine Thu, 25 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/155268.php http://www.medicalnewstoday.com/articles/155268.php Advaxis, Incorporated (OTCBB: ADXS), has engaged the Numoda Corporation, a leading clinical trial and logistics management company, to oversee Phase II clinical activity with ADXS11-001 for the treatment of invasive cervix cancer and cervical intraepithelial neoplasia (CIN; cervical dysplasia). Numoda will integrate oversight and logistical functions with the clinical research organizations (CRO), contract laboratories, academic laboratories and statistical groups involved. Cervical Cancer / HPV Vaccine Wed, 24 Jun 2009 10:00:00 PDT http://www.medicalnewstoday.com/articles/155236.php http://www.medicalnewstoday.com/articles/155236.php Genital warts are also called venereal warts or condylomata acuminate. Genital warts are one of the most common kinds of STDs (sexually transmitted diseases) or STIs (sexually transmitted infections). According to Medilexicon's Sexual Health / STDs Wed, 24 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/155065.php http://www.medicalnewstoday.com/articles/155065.php Judicial Watch, the public interest group that investigates and prosecutes government corruption, announced today that it has obtained records from the Food and Drug Administration (FDA) documenting 28 deaths in 2008 associated with Gardasil, the vaccination for human papillomavirus (HPV), up from the 19 deaths in 2007. The total number of Gardasil-related deaths is 47 since the vaccine was approved in 2006. Cervical Cancer / HPV Vaccine Fri, 19 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/154547.php http://www.medicalnewstoday.com/articles/154547.php Combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase the detection of cervical cancer compared with LBC screening alone, according to an Article published Online first and in the July edition of The Lancet Oncology. Cervical Cancer / HPV Vaccine Fri, 19 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154570.php http://www.medicalnewstoday.com/articles/154570.php An article published Online First and in the July edition of The Lancet Oncology reports that the combination of human papillomavirus (HPV) testing with regular liquid-based cytology (LBC) screening does not improve the detection of cervical cancer compared with LBC screening alone. In the UK, liquid-based cytology (which is a liquid form of the Pap smear test) has replaced the conventional Pap smear test. Cervical Cancer / HPV Vaccine Sat, 13 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/153642.php http://www.medicalnewstoday.com/articles/153642.php Fear plays a major role in whether women decide to go for cancer screening or not, but healthcare providers underestimate how much women need to know and wrongly assume that they will ask for information if they want it. Those are the two key findings from a study published in the June issue of the UK-based Journal of Advanced Nursing. Cervical Cancer / HPV Vaccine Fri, 12 Jun 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/153626.php http://www.medicalnewstoday.com/articles/153626.php In a posting aimed at health care professionals, FDA on its Web site on Wednesday said that recipients of Merck's human papillomavirus vaccine, Gardasil, should be closely observed afterward for 15 minutes while they remain seated or lying down to avoid the possibility of fainting, the Wall Street Journal reports. Cervical Cancer / HPV Vaccine Thu, 11 Jun 2009 09:00:00 PDT http://www.medicalnewstoday.com/articles/153589.php http://www.medicalnewstoday.com/articles/153589.php Human papillomavirus (HPV) is an important causative agent in squamous cell cancers of head and neck (HNSCC) a new meta-analysis presented at the American Society of Clinical Oncology (ASCO) confirms; but a separate European survey at the same meeting reveals the public is woefully ignorant about it and possible ways to avoid it. Sexual Health / STDs Sun, 07 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/152804.php http://www.medicalnewstoday.com/articles/152804.php Cervical Cancer Awareness Week 8-14 June 2009 is a key time to remind women that it is of huge importance that they attend their screening appointment when asked. The Improvement Foundation (IF) aim to help tackle the decline in screening uptake by addressing levels of complacency among clinicians and the public through their national Cervical Screening Improvement Programme. Cervical Cancer / HPV Vaccine Fri, 05 Jun 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/152765.php http://www.medicalnewstoday.com/articles/152765.php Advaxis, Inc. (OTCBB:ADXS) received the FDA letter late on June 1 denying the company's request for Orphan Drug Designation (ODD) for the use of ADXS11-001 in invasive cervix cancer. The FDA stated their market definition for invasive cervical cancer prevalence (including all those who had been cured) is over the 200,000 person cutoff. Cervical Cancer / HPV Vaccine Fri, 05 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/152645.php http://www.medicalnewstoday.com/articles/152645.php Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida State University study. Cervical Cancer / HPV Vaccine Thu, 04 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/152534.php http://www.medicalnewstoday.com/articles/152534.php Merck's human papillomavirus vaccine, Gardasil, was 90% effective in preventing infection with the virus and cervical disease in women ages 24 to 45, according to a study published Monday in the medical journal Lancet, Cervical Cancer / HPV Vaccine Wed, 03 Jun 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/152434.php http://www.medicalnewstoday.com/articles/152434.php Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida State University study. Cervical Cancer / HPV Vaccine Tue, 02 Jun 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/152224.php http://www.medicalnewstoday.com/articles/152224.php The four-type (6, 11, 16, 18) human papillomavirus (HPV) vaccine, Gardasil® has been awarded World Health Organization (WHO) pre-qualification. It is the first cervical cancer vaccine to receive WHO pre-qualification. Cervical Cancer / HPV Vaccine Tue, 02 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/152137.php http://www.medicalnewstoday.com/articles/152137.php An article published Online First and in an upcoming edition of The Lancet reports that women aged between 24 and 45 can be protected by the human papilloma virus (HPV) vaccine, if they have not been already infected by the virus. The report is the work of Dr Nubia Muñoz, from the National Institute of Cancer, Bogotá, Colombia, and collaborators. Over the last thirty years, sexual behavior has changed. The age of the first marriage is rising, divorce rates are augmenting. Cervical Cancer / HPV Vaccine Tue, 02 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/152199.php http://www.medicalnewstoday.com/articles/152199.php The four-type (6,11,16,18) human papillomavirus (HPV) vaccine, Gardasil®, has been chosen by the Norwegian authorities for the national vaccination programme after the assessment of a variety of criteria, including efficacy in the prevention of cervical cancer, safety and evidence of long-lasting protection. All available data was considered, including new data presented during the 25th International Papillomavirus Conference (IPC) in May in Malmö, Sweden. Cervical Cancer / HPV Vaccine Tue, 02 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/152110.php http://www.medicalnewstoday.com/articles/152110.php A new surgical technique could allow surgeons to perform a radical hysterectomy in patients with early-stage cervical cancer-with fewer complications, reduced morbidity, and a lower risk of local tumour recurrence than current surgical methods, according to an Article published Online first and in the July edition of The Lancet Oncology. Cervical Cancer / HPV Vaccine Thu, 28 May 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/151690.php http://www.medicalnewstoday.com/articles/151690.php Researchers at Roswell Park Cancer Institute (RPCI) in Buffalo, New York, are strongly advocating a national discussion about the need to vaccinate both young men and women against HPV 16 to prevent head & neck cancers. The call comes amid growing evidence that certain cancers of the head and neck are strongly linked to Cervical Cancer / HPV Vaccine Thu, 28 May 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/151604.php http://www.medicalnewstoday.com/articles/151604.php Mice and rabbits immunized with a multimeric-L2 protein vaccine had robust antibody responses and were protected from infection when exposed to human papillomavirus (HPV) type 16 four months after vaccination, according to a new study published in the May 26 online issue of the Journal of the National Cancer Institute. Cervical Cancer / HPV Vaccine Thu, 28 May 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/151605.php http://www.medicalnewstoday.com/articles/151605.php Mice and rabbits immunized with a multimeric-L2 protein vaccine had robust antibody responses and were protected from infection when exposed to human papillomavirus (HPV) type 16 four months after vaccination, according to a new study published in the May 26 online issue of the Journal of the National Cancer Institute. Cervical Cancer / HPV Vaccine Wed, 27 May 2009 07:00:00 PDT http://www.medicalnewstoday.com/articles/151581.php http://www.medicalnewstoday.com/articles/151581.php GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification. GARDASIL is the first cervical cancer vaccine to receive WHO pre-qualification. Cervical Cancer / HPV Vaccine Wed, 27 May 2009 07:00:00 PDT http://www.medicalnewstoday.com/articles/151585.php http://www.medicalnewstoday.com/articles/151585.php Zetiq, a subsidiary of Bio-Light Ltd. (TASE:BOLT), reports the successful completion of a clinical trial to validate feasibility of early identification of cervical cancer. The trial was conducted on cervical smears collected from 74 subjects at Meir MC and Macabbi health services in Israel. Cervical Cancer / HPV Vaccine